Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
452.86
-0.50 (-0.11%)
Streaming Delayed Price
Updated: 9:54 AM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
52,254
Open
454.34
Bid (Size)
452.44 (40)
Ask (Size)
453.38 (40)
Prev. Close
453.36
Today's Range
448.52 - 455.00
52wk Range
362.50 - 519.68
Shares Outstanding
259,428,394
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Vertex Pharmaceuticals Inc (NASDAQ:VRTX) Emerges as a Compelling Value Stock Candidate
↗
January 01, 2026
Via
Chartmill
The Best Stocks to Invest $1,000 in to Start the New Year Off Right
↗
January 01, 2026
These three stocks could make 2026 a happy new year for investors.
Via
The Motley Fool
Topics
Artificial Intelligence
Performance
YTD
N/A
N/A
1 Month
+4.6%
+4.6%
3 Month
+10.8%
+10.8%
6 Month
-1.5%
-1.5%
1 Year
+11.6%
+11.6%
More News
Read More
Biotech’s Resurgence: How a Year-End Rally and M&A Frenzy Set the Stage for 2026
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Stay informed with the top movers within the S&P500 index on Tuesday.
↗
December 30, 2025
Via
Chartmill
Discover which S&P500 stocks are making waves on Tuesday.
↗
December 30, 2025
Via
Chartmill
2 Growth Stocks to Buy For 2026 and Beyond
↗
December 30, 2025
Via
The Motley Fool
Topics
Economy
2 Nasdaq 100 Stocks Worth Investigating and 1 We Turn Down
December 28, 2025
Via
StockStory
Topics
Electric Vehicles
World Trade
3 Supercharged Growth Stocks to Buy and Hold Into the 2030s
↗
December 28, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Forget Moderna Stock, This is a Much Better Buy
↗
December 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
The $1.7 Billion Pivot: Agios Pharmaceuticals (AGIO) and the New Frontier of Oral Thalassemia Therapy
December 24, 2025
Via
PredictStreet
Topics
Economy
Is CRISPR Therapeutics Stock Yesterday's News?
↗
December 24, 2025
Via
The Motley Fool
Vertex to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 12
December 22, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Moderna (MRNA): The “Act 2” of an mRNA Pioneer – A 2025 Deep Dive
December 22, 2025
Via
PredictStreet
Topics
Earnings
Initial Public Offering
Intellectual Property
Vertex Pharmaceuticals Inc (NASDAQ:VRTX): A GARP Case Study in Affordable Growth
↗
December 22, 2025
Via
Chartmill
2 Cash-Producing Stocks to Consider Right Now and 1 We Find Risky
December 21, 2025
Via
StockStory
Is CRISPR Therapeutics a Buy, Sell, or Hold in 2026?
↗
December 19, 2025
Via
The Motley Fool
2 Reasons to Watch VRTX and 1 to Stay Cautious
December 17, 2025
Via
StockStory
Topics
Stocks
From Insulin Injections to Functional Cures: Regenerative Medicine Reshapes Diabetes
December 16, 2025
From
USA News Group
Via
GlobeNewswire
12 Days of Investing: My Top 12 Stocks to Buy Before 2026
↗
December 15, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Vertex Pharmaceuticals (NASDAQ:VRTX) Combines Strong Growth with Technical Breakout Potential
↗
December 15, 2025
Via
Chartmill
2 Healthcare Stocks to Buy Ahead of the New Year
↗
December 12, 2025
Via
The Motley Fool
Beyond AI: How Non-AI Tech Innovations are Fueling a New Era of Stock Market Growth
December 11, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Emissions
1 Large-Cap Stock to Consider Right Now and 2 Facing Challenges
December 08, 2025
Via
StockStory
Down 10%, Should You Buy the Dip on Vertex Pharmaceuticals?
↗
December 06, 2025
Via
The Motley Fool
Vertex Presents New Data on CASGEVY®, Including First-Ever Data in Children Ages 5-11 Years, at the American Society of Hematology Annual Meeting and Announces Plan for Global Regulatory Submissions
December 06, 2025
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Frequently Asked Questions
Is Vertex Pharmaceuticals publicly traded?
Yes, Vertex Pharmaceuticals is publicly traded.
What exchange does Vertex Pharmaceuticals trade on?
Vertex Pharmaceuticals trades on the Nasdaq Stock Market
What is the ticker symbol for Vertex Pharmaceuticals?
The ticker symbol for Vertex Pharmaceuticals is VRTX on the Nasdaq Stock Market
What is the current price of Vertex Pharmaceuticals?
The current price of Vertex Pharmaceuticals is 452.86
When was Vertex Pharmaceuticals last traded?
The last trade of Vertex Pharmaceuticals was at 01/02/26 09:54 AM ET
What is the market capitalization of Vertex Pharmaceuticals?
The market capitalization of Vertex Pharmaceuticals is 117.48B
How many shares of Vertex Pharmaceuticals are outstanding?
Vertex Pharmaceuticals has 117B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.